L. CASEI DG® (LACTOBACILLUS PARACASEI CNCMI1572; ENTEROLACTIS®PLUS) IN THE TREATMENT OF PATIENTS WITH IRRITABLE BOWEL SYNDROME: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLELGROUP, PLACEBO CONTROLLED STUDY

Start/End Date

2017 – ongoing

Principal Investigator

Prof. Michele Cicala

Host Institution

Unità Operativa Complessa di Gastroenterologia, Università Campus Biomedico di Roma

Funding source

Azienda farmaceutica SOFAR S.p.A. (promotore dello studio)